Koller, Erich <br/><br/>
Use of a chemically modified antisense oligonucleotide library to identify and validate Eg5 (kinesin-like 1) as a target for antineoplastic drug development.  [electronic resource] 

 -  Cancer research  Feb 2006 
 - 2059-66 p.  digital 
<br/><br/> Publication Type: Journal Article 
<br/><br/><label>ISSN: </label>0008-5472 
<br/><br/><label>Standard No.: </label>10.1158/0008-5472.CAN-05-1531  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Animals<br/>Antineoplastic Agents--pharmacology<br/>Apoptosis--drug effects<br/>Breast Neoplasms--drug therapy<br/>Cell Growth Processes--drug effects<br/>Cell Line, Tumor<br/>DNA, Neoplasm--genetics<br/>Gene Library<br/>Glioma--drug therapy<br/>HeLa Cells<br/>Humans<br/>Kinesins--antagonists & inhibitors<br/>Mice<br/>Mice, Nude<br/>Oligonucleotides, Antisense--genetics<br/>RNA, Messenger--antagonists & inhibitors<br/>Xenograft Model Antitumor Assays